scispace - formally typeset
B

Brendan Doe

Researcher at Wellcome Trust Sanger Institute

Publications -  20
Citations -  2289

Brendan Doe is an academic researcher from Wellcome Trust Sanger Institute. The author has contributed to research in topics: Gene & CRISPR. The author has an hindex of 11, co-authored 19 publications receiving 1736 citations. Previous affiliations of Brendan Doe include Wellcome Trust.

Papers
More filters
Journal ArticleDOI

High-throughput discovery of novel developmental phenotypes

Mary E. Dickinson, +85 more
- 22 Sep 2016 - 
TL;DR: It is shown that human disease genes are enriched for essential genes, thus providing a dataset that facilitates the prioritization and validation of mutations identified in clinical sequencing efforts and reveals that incomplete penetrance and variable expressivity are common even on a defined genetic background.
Journal ArticleDOI

Juno is the egg Izumo receptor and is essential for mammalian fertilization

TL;DR: It is shown that the Izumo1–Juno interaction is conserved within several mammalian species, including humans, and it is proposed to rename it Juno to provide opportunities for the rational development of new fertility treatments and contraceptives.
Journal ArticleDOI

The mammalian gene function resource: the international knockout mouse consortium

Allan Bradley, +83 more
- 12 Sep 2012 - 
TL;DR: The IKMC materials considerably enhance functional gene annotation of the mammalian genome and will have a major impact on future biomedical research.
Journal ArticleDOI

No unexpected CRISPR-Cas9 off-target activity revealed by trio sequencing of gene-edited mice

TL;DR: If CRISPR mutagenesis were causing SNV or indel off-target mutations in treated embryos, then the number of these mutations is not statistically distinguishable from the background rate of DNMs occurring due to other processes.